SCLX

Scilex Holding Co

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE · CIK 0001820190
$5.76 -2.70% $50.3M
Insider Buying Cluster (2 insiders)High Impact Filing (8/10)
Vol
Market Cap$50.3M
Cap SizeMicro Cap
Inst. Holders6 funds
Inst. Value$4.3M
Inst. Activity1 buys / 2 sells
Insider Activity2B / 1S
Insider Net $$499.9K
SEC Reports2
Press Releases2
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001820190·Prev Close $5.92

Analyst Ratings

Historical distribution0% buy · 6 analysts · last covering-analyst action Apr 2025
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
DateFirmActionRating
Apr 11, 2025 D. Boral Capital DOWNGRADE Buy → Hold
Apr 2, 2025 D. Boral Capital MAINTAIN Buy → Buy
Feb 28, 2025 D. Boral Capital MAINTAIN Buy → Buy
Jan 27, 2025 D. Boral Capital INITIATE Buy
Oct 21, 2024 HC Wainwright & Co. REITERATE Buy → Buy

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$3.6MNEW
RENAISSANCE TECHNOLOGIES LLC$469.3KDOUBLED
MORGAN STANLEY$178.2KTRIM
BANK OF AMERICA CORP$90.4KTRIM
WELLS FARGO & COMPANY/MN$1.5KTRIM

Recent Insider Trades

DateInsiderTypeValue
Apr 17, 2026Ji HenrySELL$100.0K
Apr 17, 2026Ma StephenBUY$100.0K
Apr 16, 2026Ji HenryBUY$499.9K
6 institutional holders with $4.3M total value (355,632 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net selling activity: 2 institutions trimmed/exited vs 1 added.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC295,024$3.6M83.0%NEW
2RENAISSANCE TECHNOLOGIES LLC38,464$469.3K10.8%DOUBLED +100.7%
3MORGAN STANLEY14,606$178.2K4.1%TRIM -36.9%
4BANK OF AMERICA CORP /DE/7,410$90.4K2.1%TRIM -57.4%
5WELLS FARGO & COMPANY/MN121$1.5K0.0%TRIM -60.4%
6FMR LLC7$85.000.0%DOUBLED +496.5%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCDOUBLED19,16438,464+100.7%$469.3K2025-Q4
MORGAN STANLEYTRIM23,15614,606-36.9%$178.2K2025-Q4
BANK OF AMERICA CORP /DE/TRIM17,3877,410-57.4%$90.4K2025-Q4
UBS Group AGADD18,42625,650+39.2%$504.8K2025-Q3
MORGAN STANLEYADD18,05423,156+28.3%$455.7K2025-Q3
RENAISSANCE TECHNOLOGIES LLCNEW19,164$377.1K2025-Q3
BANK OF AMERICA CORP /DE/ADD9,60417,387+81.0%$342.2K2025-Q3
WELLS FARGO & COMPANY/MNTRIM260103-60.4%$2.0K2025-Q3
NORGES BANKEXIT13,6440-100.0%$0.002025-Q3
VANGUARD GROUP INCNEW294,314$1.7M2025-Q2
UBS Group AGNEW18,426$108.5K2025-Q2
MORGAN STANLEYNEW18,054$106.3K2025-Q2
NORGES BANKNEW13,644$80.4K2025-Q2
BANK OF AMERICA CORP /DE/NEW9,604$56.6K2025-Q2
BANK OF AMERICA CORP /DE/EXIT52,3940-100.0%$0.002025-Q2
VANGUARD GROUP INCEXIT5,897,7150-100.0%$0.002025-Q2
MORGAN STANLEYEXIT334,8860-100.0%$0.002025-Q2
UBS Group AGEXIT731,5410-100.0%$0.002025-Q2
RENAISSANCE TECHNOLOGIES LLCEXIT66,5000-100.0%$0.002025-Q2
TWO SIGMA INVESTMENTS, LPEXIT44,4580-100.0%$0.002025-Q2
UBS Group AGDOUBLED97,335731,541+651.6%$181.4K2025-Q1
MORGAN STANLEYTRIM507,404334,886-34.0%$83.2K2025-Q1
RENAISSANCE TECHNOLOGIES LLCNEW66,500$16.5K2025-Q1
TWO SIGMA INVESTMENTS, LPTRIM61,00544,458-27.1%$11.0K2025-Q1
FMR LLCDOUBLED4,87429,075+496.5%$7.2K2025-Q1
2 unique insiders with 3 transactions. Net insider value: $499.9K ($599.8K bought, $100.0K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Apr 17, 2026Ji HenryExec Chair, CEO and PresidentSELL650,000$0.1538$100.0K
Apr 17, 2026Ma Stephen HoiCFO, COO and SecretaryBUY650,000$0.1538$100.0K
Apr 16, 2026Ji HenryExec Chair, CEO and PresidentBUY3,250,000$0.1538$499.9K
Historical analyst distribution (last covering-analyst action Apr 2025): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2026-06-30
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
5 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 5 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Apr 11, 2025 D. Boral Capital DOWNGRADE Buy Hold
Apr 2, 2025 D. Boral Capital MAINTAIN Buy Buy
Feb 28, 2025 D. Boral Capital MAINTAIN Buy Buy
Jan 27, 2025 D. Boral Capital INITIATE Buy
Oct 21, 2024 HC Wainwright & Co. REITERATE Buy Buy
Oct 16, 2024 Alliance Global Partners INITIATE Buy
Jun 17, 2024 HC Wainwright & Co. REITERATE Buy Buy
Jun 13, 2024 Rodman & Renshaw INITIATE Buy
Jun 11, 2024 HC Wainwright & Co. REITERATE Buy Buy
May 23, 2024 HC Wainwright & Co. MAINTAIN Buy Buy
May 3, 2024 HC Wainwright & Co. MAINTAIN Buy Buy
Dec 4, 2023 HC Wainwright & Co. REITERATE Buy Buy
Oct 13, 2023 B. Riley Securities INITIATE Buy
Oct 9, 2023 HC Wainwright & Co. INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 2026003120%
Apr 1, 2026003120%
Mar 1, 2026003120%
Feb 1, 2026003120%
Jan 1, 2026003120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 20, 2026
earnings_calendar
SCLX Q1 2026 Earnings Scheduled — 2026-05-20
May 13, 2026
earnings_calendar
SCLX Q1 2026 Earnings Scheduled — 2026-05-13
May 12, 2026
earnings_calendar
SCLX Q1 2026 Earnings Scheduled — 2026-05-12
May 5, 2026
m_and_a
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
<p>PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gene
May 4, 2026
dividend
Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026
<p>PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gene
Apr 6, 2026
earnings_calendar
SCLX Q4 2025 Earnings Before Market Open — 2026-04-06
Mar 30, 2026
earnings_calendar
SCLX Q4 2025 Earnings Before Market Open — 2026-03-30
Mar 13, 2026
other
Scilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related Parties
<p align="left">PALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovati